Remove 2028 Remove Drug Development Remove Packaging
article thumbnail

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

Carbon contributing factors: The mitigating factors throughout the drug development process The carbon-contributing factors in the production and distribution of Capsugel capsules at Lonza can be categorised into three main areas: upstream, operational, and downstream activities.

Dosage 104
article thumbnail

Five potential EU regulatory changes impacting the life sciences industry in 2023

European Pharmaceutical Review

Launch of the EU pharmaceutical package The European Commission plans to commence initiatives relating to the European Pharmaceutical Strategy (strategy) with the publication of the revised EU pharmaceutical package scheduled during the first quarter of 2023. of the MDR and Article 110.4

Packaging 117
article thumbnail

CureVac to Be Acquired by BioNTech in $1.25B Deal to Advance mRNA Cancer Therapies

PharmaTech

By combining assets, both companies aim to streamline mRNA drug development pipelines and manufacturing workflows, potentially reducing timelines for delivering clinical-stage therapies to patients. This news comes just 10 days after BioNTech announced a global co-development and co-commercialization agreement valued at up to $11.1

Dosage 52